Abstract:Objective:To investigate diagnostic and prognostic evaluation values of abdominal ultrasonography combined with serum interleukin(IL)-6 level in neonatal necrotizing enterocolitis (NEC).Methods:A total of 138 neonates with NEC treated in neonatal intensive care unit (NICU) of 3201 Hospital from March 2018 to March 2020 were enrolled into NEC group, and 65 newborns born in the same hospital and treated in NICU also during the same period were selected into non-NEC group. According to Bell-NEC grading standard, neonates in NEC group were furtherly divided into suspected subgroup (n=79) and diagnosed subgroup (n=59). According to treatment methods, neonates in NEC group were furtherly divided into medical treatment subgroup (n=94) and operation subgroup (n=44). The clinical data of neonates in two groups were retrospectively analyzed. Clinical data (including serum IL-6 level at admission) of neonates between NEC group and non-NEC group, also abdominal ultrasonography diagnostic indexes of NEC and serum IL-6 level of neonates between NEC subgroups were statistically compared by chi-square test and independent-samples t test. Independent risk factors of NEC in neonates were analyzed by multivariate non-conditional logistic regression analysis. Receiver operating characteristic (ROC) curve was used to evaluate the diagnostic value of abdominal ultrasonography, serum IL-6 level and their combination for NEC. According to critical value of serum IL-6 level of ROC curve and five abdominal ultrasonography indexes with statistically significant differences between NEC medical treatment subgroup and operation subgroup, neonates in NEC group were divided into subgroup A (n=18, serum IL-6>6.25 ng/mL + with all of positive five ultrasonography indexes), and subgroup B (n=25, serum IL-6≤6.25 ng/mL + with all of negative five ultrasonography indexes), and subgroup C (n=95, other NEC neonates except subgroup A and B). Kaplan-Meier survival curve analysis was used to compare the 1-year survival rates of subgroups A, B and C. This study was approved by the Medical Ethics Committee of 3201 Hospital (Approval No.[2022]004). All guardians of subjects gave informed consent to the study and signed informed consents for clinical study.Results:① The proportion of premature infants, incidence of amniotic fluid meconium contamination and neonatal sepsis, serum IL-6 level at admission, incidence of maternal gestational diabetes, premature rupture of membranes and infection, and starting time of breast-feeding in NEC group were higher or longer than those in non-NEC group, while breast-feeding rate and utilization rate of probiotics were lower than those in non-NEC group, and all the differences were statistically significant (P<0.05). ② Multivariate logistic regression analysis showed that preterm birth (OR=2.624, 95%CI: 1.269-3.451, P=0.035), amniotic fluid meconium contamination (OR=1.847, 95%CI: 1.358-2.634, P=0.028), neonatal sepsis (OR=4.006, 95%CI: 3.039-5.138, P=0.022), maternal gestational diabetes mellitus (OR=1.653, 95%CI: 1.142-2.869, P=0.012), non-exclusive breastfeeding (OR=1.480, 95%CI: 1.028-2.366, P=0.006), no probiotics prophylaxis (OR=3.318, 95%CI: 1.235-3.959, P<0.001) and serum IL-6>6.25 ng/mL (OR=2.314, 95%CI: 1.497-4.247, P=0.018) were all independent risk factors of NEC in neonates. ③ Abdominal ultrasonography detection rates of intestinal wall thickening, portal venous air accumulation, intestinal dilatation, reduced intestinal inflation, intestinal peristalsis disappearance, peritoneal effusion (poor ultrasound transmission) and reduced intestinal wall blood perfusion in NEC diagnosed subgroup were higher than those in NEC suspected subgroup, and the differences were statistically significant (P<0.05). ④ ROC curve analysis showed that the area under curve (AUC) of ROC of abdominal ultrasonography combined with serum IL-6 level in diagnosis of NEC was 0.854 (95%CI: 0.781-0.927, P<0.001). The ROC-AUC, sensitivity, specificity, positive predictive value and negative predictive value of their combination for diagnosis of NEC were higher than those of abdominal ultrasonography and serum IL-6 level, respectively, and the differences were statistically significant (P<0.05). ⑤ Abdominal ultrasonography detection rates of intestinal wall thickening, intestinal dilation, reduced intestinal inflation, intestinal peristalsis disappearance and peritoneal effusion (poor ultrasound transmission), and serum IL-6 level at admission in NEC operation subgroup were significantly higher than those in NEC medical treatment subgroup, and the differences were statistically significant (P<0.05). ⑥ The 1-year survival rate of subgroup B was 88.0%, which was higher than that of subgroup A (55.6%) and subgroup C (69.5%), respectively, and the differences were statistically significant (P<0.05).Conclusion:Abdominal ultrasonography combined with serum IL-6 level can improve diagnostic rate of neonatal NEC, and has good prognostic evaluation values for NEC children.

Screening inflammatory protein biomarkers on premature infants with necrotizing enterocolitis

Utility of Cytokines to Predict Neonatal Sepsis.

Quantitative Proteomic Analysis Identifying and Evaluating TRAF6 and IL-8 as Potential Diagnostic Biomarkers in Neonatal Patients with Necrotizing Enterocolitis

[Expression of Neutrophil Adhesion Molecule CD11b As an Early Diagnostic Marker for Neonatal Sepsis].

Inflammatory biomarkers and physiomarkers of late-onset sepsis and necrotizing enterocolitis in premature infants

Biomarkers in the Severity of Necrotizing Enterocolitis in Preterm Infants: A Pilot Study

Data-independent acquisition-based blood proteomics unveils predictive biomarkers for neonatal necrotizing enterocolitis

IP-10 Is an Early Diagnostic Marker for Identification of Late-Onset Bacterial Infection in Preterm Infants

IL-27 as a potential biomarker for distinguishing between necrotising enterocolitis and highly suspected early-onset food protein-induced enterocolitis syndrome with abdominal gas signs

Identification of Inflammatory Genes, Pathways, and Immune Cells in Necrotizing Enterocolitis of Preterm Infant by Bioinformatics Approaches

I-FABP protein/mRNA and IL-6 as biomarkers of intestinal barrier dysfunction in neonates with necrotizing enterocolitis and SPF BALB/c mouse models

Elevated levels of circulating cell-free DNA and neutrophil proteins are associated with neonatal sepsis and necrotizing enterocolitis in immature mice, pigs and infants

Gut microbiota and short-chain fatty acids may be new biomarkers for predicting neonatal necrotizing enterocolitis: A pilot study

Early-Onset Neonatal Sepsis: Inflammatory Biomarkers and MicroRNA as Potential Diagnostic Tools in Preterm Newborns

Diagnostic and prognostic evaluation values of abdominal ultrasound combined with interleukin-6 detection in neonatal necrotizing enterocolitis

Characteristics of Neonatal Sepsis and Predictive Values of Polyfunctional Assessment of Umbilical Cord Neutrophils Based on Single Cell Proteomic Secretion

Serum Relmβ combined with abdominal signs may predict surgical timing in neonates with NEC: A cohort study

Application of Coagulation Parameters at the Time of Necrotizing Enterocolitis Diagnosis in Surgical Intervention and Prognosis

Fecal HBD-2 and Claudin-3 may be potential biomarkers to predict the deterioration of necrotizing enterocolitis: A prospective study

CD16+CD163+ monocytes traffic to sites of inflammation during necrotizing enterocolitis in premature infants

Proteomics Profiling of Stool Samples from Preterm Neonates with SWATH/DIA Mass Spectrometry for Predicting Necrotizing Enterocolitis